20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one) | Trials (7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one) | Recent Studies (post-2010) (7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 217 | 0 | 16 |
| Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one (IC50) |
|---|---|---|---|
| Substance-P receptor | Homo sapiens (human) | 0.03 | |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | 0.032 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahluwalia, A; Baker, MD; Bubb, KJ; Chan, MV; Finsterbusch, M; Khan, FJ; Panayiotou, CM; Priestley, JV; Wen, H | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one
| Article | Year |
|---|---|
Activation of neuronal transient receptor potential vanilloid 1 channel underlies 20-hydroxyeicosatetraenoic acid-induced vasoactivity: role for protein kinase A.
Topics: Animals; Blood Pressure; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Female; Hydroxyeicosatetraenoic Acids; Isoindoles; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Sex Characteristics; TRPV Cation Channels; Vasoconstriction | 2013 |